$LYB

LyondellBasell Industries N.V. (LYB): Results of Operations and Financial Condition

LyondellBasell Industries N.V. (LYB) filed an SEC Form 8-K — Results of Operations and Financial Condition. NEWS RELEASE FOR IMMEDIATE RELEASE HOUSTON and LONDON, July 31, 2026 LyondellBasell reports second quarter 2026 earnings • Net income: $0.6 billion, $1.4 billion excluding identified items 1 • Diluted earnings per share: $1.71 per share; $4.30 per share excluding identified items

Original reporting
Published Jul 31, 2026, 10:31 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 10:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LYB
Bullish
medium confidence
Mentioned
$LYB
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$LYBBullishMed
01

Why it matters

Traders can use the segment EBITDA and operating income changes versus both Q1 2026 and prior-year periods to update near-term earnings expectations, especially where management ties improvements to pricing/margin strength from supply constraints.

02

Market read

Fresh segment financials and management’s stated drivers (margin expansion from supply constraints) provide actionable inputs for chemical-cycle positioning.

03

What to watch

The filing includes identified items such as asset write-downs, cash improvement plan costs, and a European asset disposition loss, which can distort underlying earnings power versus headline EBITDA.

Relevance 7/10Novelty 6/10Timing: filed pre-market today (2026-07-31) with Q2 results discussion
alphai · Earnings readLYB · Three months ended June 30, 2026 · ended June 30, 2026

Segment EBITDA improved sequentially across all five operating segments, while O&P-EAI reported a loss on the disposition of select European olefins and polyolefins assets and associated businesses.

Mixed quarter

Sequential underlying EBITDA excluding identified items increased in every operating segment, led by O&P-Americas, but reported O&P-EAI EBITDA was negative due to a loss on sale of business.

Olefins & Polyolefins-Americas
Not reported

Key metrics

as reported
MetricValueq/qy/y
O&P-Americas operating incomeGAAP$1,003 million
O&P-Americas EBITDAnon-GAAP$1,183 millionincreased by $856 million
O&P-Americas asset write-downsother$74 million
O&P-Americas Cash Improvement Plan costsother$10 million
O&P-Americas EBITDA excluding identified itemsnon-GAAP$1,267 millionincreased by $940 million
O&P-EAI operating income (loss)GAAP$158 million
O&P-EAI EBITDAnon-GAAP$(432) milliondecreased by $397 million
O&P-EAI loss on sale of businessother$734 million
O&P-EAI asset write-downsother
O&P-EAI Cash Improvement Plan costsother$8 million
O&P-EAI site closure costsother$32 million
O&P-EAI European transaction costs, net of transition service agreement incomeother$(11) million
O&P-EAI EBITDA excluding identified itemsnon-GAAP$331 millionincreased by $337 million
I&D operating incomeGAAP$268 million
I&D EBITDAnon-GAAP$377 millionincreased by $153 million
I&D Cash Improvement Plan costsother$9 million
I&D site closure costsother
I&D EBITDA excluding identified itemsnon-GAAP$386 millionincreased by $162 million
APS operating incomeGAAP$57 million
APS EBITDAnon-GAAP$77 millionincreased by $19 million
APS Cash Improvement Plan costsother$3 million
APS site closure costsother$(2) million
APS EBITDA excluding identified itemsnon-GAAP$78 millionincreased by $20 million
Technology operating incomeGAAP$63 million
Technology EBITDAnon-GAAP$73 millionincreased by $55 million
Technology Cash Improvement Plan costsother$1 million
Technology EBITDA excluding identified itemsnon-GAAP$74 millionincreased by $56 million
O&P-Americas operating income, six months ended June 30, 2026GAAP$1,145 million
O&P-Americas EBITDA, six months ended June 30, 2026non-GAAP$1,510 millionincreased $946 million
O&P-Americas EBITDA excluding identified items, six months ended June 30, 2026non-GAAP$1,594 millionincreased $1,025 million
O&P-EAI operating income (loss), six months ended June 30, 2026GAAP$90 million
O&P-EAI EBITDA, six months ended June 30, 2026non-GAAP$(467) milliondecreased $486 million
O&P-EAI EBITDA excluding identified items, six months ended June 30, 2026non-GAAP$325 millionincreased $262 million
I&D operating income, six months ended June 30, 2026GAAP$386 million
I&D EBITDA, six months ended June 30, 2026non-GAAP$601 millionincreased $221 million
I&D EBITDA excluding identified items, six months ended June 30, 2026non-GAAP$610 millionincreased $109 million
APS operating income, six months ended June 30, 2026GAAP$95 million
APS EBITDA, six months ended June 30, 2026non-GAAP$135 millionincreased $57 million
APS EBITDA excluding identified items, six months ended June 30, 2026non-GAAP$136 millionincreased $50 million
Technology operating income, six months ended June 30, 2026GAAP$70 million
Technology EBITDA, six months ended June 30, 2026non-GAAP$91 millionincreased $6 million
Technology EBITDA excluding identified items, six months ended June 30, 2026non-GAAP$92 million

Segments

SegmentRevenueq/qy/y
Olefins & Polyolefins-AmericasStronger margins across all businesses as prices increased due to industry supply constraints as a result of the conflict in the Middle East. Olefins results increased approximately $520 million and combined polyolefins results increased approximately $415 million versus the first quarter of 2026.Not reported
Olefins & Polyolefins-Europe, Asia, InternationalStronger margins across all businesses due to industry supply constraints increased EBITDA excluding identified items. The period included $734 million related to the loss on the disposition of select European olefins and polyolefins assets and associated businesses, and a gain on the sale of European emission credits of approximately $50 million.Not reported
Intermediates & DerivativesIntermediate chemicals and oxyfuels and related products results drove an increase of approximately $105 million and $65 million, respectively, driven by higher margins from improved prices as a result of tight market supply.Not reported
Advanced Polymer SolutionsHigher margins were driven by higher average sales prices due to industry supply constraints resulting from the conflict in the Middle East.Not reported
TechnologyHigher demand for catalysts accounted for approximately half of the increase in EBITDA, while the remaining increase was driven by higher licensing results as a greater number of higher-value contracts reached significant milestones.Not reported

Capital returns

  • The company paid dividends of $224 million during the second quarter 2026.
  • The company did not repurchase shares during the second quarter 2026.

What drove it

  • Industry supply constraints associated with the conflict in the Middle East supported higher prices and margins in O&P-Americas and APS.
  • O&P-Americas ethylene crackers operated at approximately 95% of capacity, with raw materials approximately 70% ethane and 30% other natural gas liquids.
  • O&P-EAI ethylene crackers operated at approximately 85% of capacity, with about 25% of raw materials derived from non-naphtha feedstocks.
  • O&P-EAI equity income increased by approximately $55 million reflecting improved margins.
  • I&D benefited from higher demand coupled with supply constraints in propylene oxide and derivatives, and from higher crude and gasoline crack spreads in oxyfuels and related products.

Concerns

  • O&P-EAI reported EBITDA of $(432) million, including a $734 million loss on sale of business.
  • Intermediate chemicals decreased approximately $35 million in the first six months of 2026 as volumes decreased due to unplanned downtime.
  • APS first-half results were partially offset by lower volumes driven by weaker demand.
  • O&P-EAI's first-half reported EBITDA decreased $486 million despite higher EBITDA excluding identified items.

What to watch

  • Whether industry supply constraints and pricing continue to support margins across olefins, polyolefins and APS.
  • O&P-EAI performance following the disposition of select European olefins and polyolefins assets and associated businesses.
  • Intermediate chemicals volumes following unplanned downtime.
  • Catalyst demand and the timing of higher-value licensing-contract milestones in Technology.
  • Any resumption of share repurchases after no repurchases during the second quarter 2026.

Balance sheet and cash flow

  • Capital expenditures, including sustaining maintenance and profit-generating growth projects, were $270 million during the second quarter 2026.
  • At the end of the quarter, cash and liquid investment balances were $2.6 billion, which includes cash and cash equivalents, restricted cash and short-term investments.
  • There were 323 million common shares outstanding as of June 30, 2026.

Analysis

The filing shows a broad sequential improvement in underlying segment profitability during the second quarter of 2026. EBITDA excluding identified items increased in all five operating segments. O&P-Americas was the principal contributor, with EBITDA excluding identified items of $1,267 million, up $940 million versus the first quarter of 2026. The company attributed the improvement to stronger margins across all businesses as prices rose amid industry supply constraints resulting from the conflict in the Middle East.

Reported O&P-EAI results were materially distorted by the disposition of select European olefins and polyolefins assets and associated businesses. The segment reported EBITDA of $(432) million and EBITDA excluding identified items of $331 million. The filing identifies a $734 million loss on sale of business, while underlying performance improved on stronger margins, increased equity income and a gain on the sale of European emission credits of approximately $50 million.

I&D, APS and Technology also improved from the first quarter. I&D EBITDA excluding identified items increased by $162 million, supported by improved prices, tight market supply and stronger oxyfuels economics. APS benefited from higher average sales prices, although its first-half comparison was partly offset by lower volumes driven by weaker demand. Technology's sequential increase reflected higher catalyst demand and licensing contracts reaching significant milestones.

Capital allocation in the quarter consisted of $270 million of capital expenditures and $224 million of dividends, with no share repurchases. Cash and liquid investment balances were $2.6 billion at quarter-end. The filing does not provide consolidated financial statements, total revenue, consolidated earnings, EPS, cash-flow results, debt or forward guidance, so the read is limited to the reported segment discussion and capital-spending information.

The main figures for investors to monitor are the durability of supply-driven margin gains, the post-disposition earnings profile of O&P-EAI, and volume trends in businesses where demand or operational downtime constrained results. The reported segment data show improved underlying profitability, but the O&P-EAI disposition loss creates a sharp difference between reported and adjusted performance.

Not in the filing

stated, not guessed
  • Consolidated total revenue
  • Revenue for each operating segment
  • Consolidated gross profit and gross margin
  • Consolidated operating income
  • Consolidated net income
  • GAAP earnings per share
  • Non-GAAP earnings per share
  • Consolidated operating cash flow
  • Free cash flow
  • Debt balances
  • Tax rate
  • Forward revenue guidance
  • Forward gross-margin guidance
  • Forward operating-expense guidance
  • Forward tax-rate guidance
  • Prior-period outlook or guidance comparison
  • Named executive quotes

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC Form 8-K (Item 2.02) with a business results discussion by operating segment for the period ended June 30, 2026.

Company-level read

Ticker impact

$LYBBullishMedium confidence
Context

LYB’s 8-K discloses Q2 segment results, including EBITDA changes driven by stronger margins and supply constraints from the Middle East conflict.

Expected impact

Near-term bias modestly positive, but magnitude depends on whether traders view the margin drivers as sustainable beyond the quarter.

Evidence & confidence

The filing provides fresh, quarter-specific financial metrics and explicit drivers (margin expansion tied to supply constraints), which can re-rate near-term earnings expectations.

Market effects

Reinforces that olefins and polyolefins pricing/margins can strengthen when supply is constrained, a read-through for chemical peers.

No explicit regional demand shock beyond Europe/Asia segment commentary; impact is primarily global commodity-cycle driven.

Middle East conflict is cited as a supply constraint driver, linking chemical margins to geopolitical energy and feedstock dynamics.

Counterpoint

Margin strength attributed to supply constraints may reverse if supply normalizes, limiting how much the quarter should lift forward estimates.

Key entities

  • LyondellBasell Industries N.V.

    Company filing the 8-K with Q2 2026 results discussion by segment and identified items.

Every LYB earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$SHELMedAI 8/10

Business Watch: DOE gives out money for batteries; Genentech licenses a GLP-1 alternative

Shell is receiving bids for its US petrochemical business, potentially worth $8 billion, from rivals like LyondellBasell and ExxonMobil, as well as private equity firms. The sale may include Shell's ethylene and polyethylene complex in Pennsylvania and other sites. LyondellBasell has a history of acquiring new plants at lower prices, while ExxonMobil is already in related businesses. Kuwait Petroleum may be interested in Shell's ethylene oxide derivatives.

$XOMHighAI 9/10

Exxon and LyondellBasell Eye Shell’s US Chemicals Portfolio – FT

Exxon Mobil (XOM) and LyondellBasell (LYB) are among potential bidders for Shell's (SHEL) US chemicals assets, valued at up to $8B. Other interested parties include Apollo and Kuwait Petroleum Corporation. The portfolio includes four facilities, with Shell seeking to divest weaker-performing operations. Shell is also reviewing European chemicals assets for potential sales.